Protein-based biomaterial with viscoelastic behaviour, process for obtaining it and uses thereof
US-2022389083-A1 · Dec 8, 2022 · US
Ovalbumin
Ovalbumin · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/77 |
| Official title | Ovalbumin |
| Display label | Ovalbumin |
| Total patents | 96 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is growing.
| Year | Patents |
|---|---|
| 2015 | 16 |
| 2016 | 10 |
| 2017 | 10 |
| 2018 | 5 |
| 2019 | 7 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 10 |
| 2023 | 12 |
| 2024 | 11 |
| 2025 | 6 |
| 2026 | 2 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
T-cell modulatory multimeric polypeptides and methods of use thereof
US-11505591-B2 · Nov 22, 2022 · US
Minimal Messenger RNAs and uses thereof
US-2022307017-A1 · Sep 29, 2022 · US
Toxoplasma platform for treating cancer
US-2022233607-A1 · Jul 28, 2022 · US
In vitro production of high affinity monoclonal antibodies
US-2022002670-A1 · Jan 6, 2022 · US
Cytosolic delivery of peptides using protein transduction domain mimics
US-2021353746-A1 · Nov 18, 2021 · US
Erythrocyte-binding therapeutics
US-2021238277-A1 · Aug 5, 2021 · US
Glycotargeting therapeutics
US-10940209-B2 · Mar 9, 2021 · US
Erythrocyte-binding therapeutics
US-10919963-B2 · Feb 16, 2021 · US
Glycotargeting therapeutics
US-2020129629-A1 · Apr 30, 2020 · US
Hybridoma cell line of secreting meloxicam monoclonal antibodies and application thereof
US-10562979-B1 · Feb 18, 2020 · US
Hybridoma cell line of secreting meloxicam monoclonal antibodies and application thereof
US-2020040106-A1 · Feb 6, 2020 · US
Erythrocyte-binding therapeutics
US-2019382479-A1 · Dec 19, 2019 · US
Phage conjugates and uses thereof
US-2019343965-A1 · Nov 14, 2019 · US
Erythrocyte-binding therapeutics
US-10392437-B2 · Aug 27, 2019 · US
T-cell modulatory multimeric polypeptides and methods of use thereof
US-2019106476-A1 · Apr 11, 2019 · US
Peptide/β-1,3-glucan complex and production method thereof and pharmaceutical composition containing peptide/β-1,3-glucan complex
US-10195270-B2 · Feb 5, 2019 · US
Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing
US-10183985-B2 · Jan 22, 2019 · US
Vault immunotherapy
US-10166277-B2 · Jan 1, 2019 · US
Glycotargeting therapeutics
US-2018303951-A1 · Oct 25, 2018 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K14/77?
- CPC C07K14/77 is the Cooperative Patent Classification code for “Ovalbumin.”
- How many patents are filed under CPC C07K14/77 (Ovalbumin)?
- Our database includes 96 publications tagged with this CPC code.
- Is patent activity under CPC C07K14/77 growing?
- Publication counts under this code: 11 in 2024 vs 6 in 2025 (latest complete years).